Publication | Open Access

The rationale for deltanoids in therapy for myeloid leukemia: Role of KSR–MAPK–C/EBP pathway

Hematological MalignancySignal TransductionImmunologyHematologyMyeloid LeukemiaKsr–mapk–c/ebp PathwayMedicineCell BiologyCell SignalingTumor BiologyMyeloid Neoplasia